ATHAGORAS Holding GmbH is building a group of leading service providers to create a tech-enabled European specialist service provider for the clinical and commercial development of healthcare innovations in the pharmaceutical & biotech industry within regulatory affairs, pharmacovigilance, as well as market access and real-world evidence.
Quantify Research and Athagoras are highly aligned in vision and commitment to client excellence. This partnership ensures that our clients will benefit from highly specialized, tech-enabled, and comprehensive launch services with a focus on Europe, as the Athagoras group develops over the next 1-2 years.
Dr. Roman-Marcus Rittweger, CEO of Athagoras, stated: “The acquisition of Quantify Research marks a significant step in our strategy to build a leading global life science consulting group. Quantify’s expertise in real-world evidence and market access complements our existing capabilities, enhancing our ability to support the life science industry and navigate the complex access landscape. We welcome the Quantify team to the Athagoras family as we work together to shape the future of market access.”
“This partnership accelerates our international expansion and strengthens our ability to deliver comprehensive real-world evidence and market access solutions to clients,” said Dr. Kirk Geale, CEO of Quantify Research. “By joining forces with Athagoras, we can leverage our unique Nordic data assets and market access expertise across a global platform, creating new opportunities for life science companies worldwide and continuing our mission to enable patient-centric healthcare.”
You can read the full press release here: https://lnkd.in/eMSw5pUd
